Quanterix stock: Q3 2026 results set for November 9

Published on 10/30/2026 at 01:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Quanterix stock is heading into a scheduled results update after the company announced its reporting date. Investors will receive a new operating update from management.

Quanterix prepares next results update

Quanterix announced the date for its third-quarter 2026 financial results and accompanying investor call.
The company said the earnings release will be issued before the webcast and conference call.

QTRX, US74766Q1013, Illustration mit AI erstellt.

Quanterix Corporation announced on October 28, 2026 that it will report its third-quarter 2026 financial results before an investor conference call. The announcement was carried by Financial Times company announcements from Business Wire.

Results release precedes investor call

Quanterix said it will publish its third-quarter results before the scheduled conference call. Management is set to discuss the figures with investors during the webcast and call, giving shareholders a fresh update on demand, execution and the companys financial trajectory.

The company said the call will take place at 8:30 a.m. Eastern Time. Investors can access the live webcast through the Investor Relations section of Quanterixs website, while an archived replay is expected to remain available for one year.

What investors will be watching

The upcoming release should provide the next reported view of revenue performance, losses, cash use and management commentary after the companys second-quarter update. The announcement itself did not provide new third-quarter financial figures or guidance, so those details remain for the results release and call.

Quanterix Corporation at a glance

Company: Quanterix Corporation
ISIN: US74766Q1013
Ticker: QTRX
Announcement: October 28, 2026
Reported period: Third quarter of 2026
Investor call: 8:30 a.m. Eastern Time on the announced results date

Quanterix develops precision biomarker technologies, including its Simoa platform, and also offers spatial biology solutions following its acquisition of Akoya Biosciences. The company describes these tools as supporting research, diagnostics and drug development.

For broader US market context, investors can follow the S&P 500 without treating index moves as a direct explanation for Quanterixs performance.

More news and analyses on Quanterix stock